Gang Wang

Dr. Gang Wang


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 July 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
GWGang Wang
Gang Wang
PLPanhong Liu
Panhong Liu
JLJiangfeng Li
Jiangfeng Li
KJKe Jin
Ke Jin
XZXiangyi Zheng
Xiangyi Zheng
LXLiping Xie
Liping Xie
Clear cell renal cell carcinoma (ccRCC) is the most common type of renal carcinoma. It is particularly important to accurately judge the prognosis of patients. Since most tumor prediction models depend on the specific expression level of related genes, a better model therefore needs to be constructed. To provide an immune-related lncRNA (irlncRNAs) tumor prognosis model that is independent of the specific gene expression levels, we first downloaded and sorted out the data on ccRCC in the TCGA database and screened irlncRNAs using co-expression analysis and then obtained the differently expressed irlncRNA (DEirlncRNA) pairs by means of univariate analysis. In addition, we modified LASSO penalized regression. Subsequently, the ROC curve was drawn, and we compared the area under the curve, calculated the Akaike information standard value of the 5-year receiver operating characteristic curve, and determined the cut-off point to establish the best model to distinguish the high- or low-disease-risk group of ccRCC. Subsequently, we reassessed the model from the perspectives of survival, clinic-pathological characteristics, tumor-infiltrating immune cells, chemotherapeutics efficacy, and immunosuppressed biomarkers. A total of 17 DEirlncRNAs pairs (AL031710.1|AC104984.5, AC020907.4|AC127-24.4,AC091185.1|AC005104.1, AL513218.1|AC079015.1, AC104564.3|HOXB-AS3, AC003070.1|LINC01355, SEMA6A-AS1|CR936218.1, AL513327.1|AS005785.1, AC084876.1|AC009704.2, IGFL2-AS1|PRDM16-DT, AC011462.4|MMP25-AS1, AL662844.3I|TGB2-AS1, ARHGAP27P1|AC116914.2, AC093788.1|AC007098.1, MCF2L-AS1|AC093001.1, SMIM25|AC008870.2, and AC027796.4|LINC00893) were identified, all of which were included in the Cox regression model. Using the cut-off point, we can better distinguish patients according to different factors, such as survival status, invasive clinic-pathological features, tumor immune infiltration, whether they are sensitive to chemotherapy or not, and expression of immunosuppressive biomarkers. We constructed the irlncRNA model by means of pairing, which can better eliminate the dependence on the expression level of the target genes. In other words, the signature established by pairing irlncRNA regardless of expression levels showed promising clinical prediction value.

11 May 2022 in Research Square
Verified
Preprint
Open access
PDF file
GWGang Wang
Gang Wang
PLPanhong Liu
Panhong Liu
JLJiangfeng Li
Jiangfeng Li
KJKe Jin
Ke Jin
XZXiangyi Zheng
Xiangyi Zheng
LXLiping Xie
Liping Xie
Background Clear cell renal cell carcinoma (ccRCC) is the most common type of renal carcinoma. It is particularly important to accurately judge the prognosis of patients. Since most tumor prediction models depend on the specific expression level of related genes. Therefore, a better model needs to be constructed. Objective To provide an immune-related lncRNA (irlncRNAs) tumor prognosis model, which independent of the specific gene expression levels. Methods First, we downloaded and sorted out the data of ccRCC in TCGA database and screened irlncRNAs by co-expression analysis, and then obtained the differently expressed irlncRNA (DEirlncRNA) pairs by univariate analysis. In addition, we modified Lasso penalized regression. Subsequently, the ROC curve was drawn, compare the area under the curve, calculate the Akaike information standard value of the 5-year receiver operating characteristic curve, and determine the cut-off point to establish the best model to distinguish the high- or low-disease-risk group of ccRCC. Subsequently, we reassessed the model from the perspectives of survival, clinic-pathological characteristics, tumor-infiltrating immune cells, chemotherapeutics efficacy, and immunosuppressed biomarkers. Results A total of 17 DEirlncRNAs pairs were identified, all of them were included in the Cox regression model. With the cut-off point, we can better distinguish patients according to different factors, such as survival status, invasive clinic-pathological features, tumor immune infiltration, whether chemotherapy is sensitive or not, and expression of immunosuppressive biomarkers. Conclusion We constructed irlncRNA model by pairing, which can better get rid of the dependence on the expression level of the target genes, to obtain a better clinical prediction.